Profile
Sector:
HealthcareIndustry:
Diagnostics & ResearchCountry:
United StatesIPO:
01 September 2022Website:
http://www.bioaffinitytech.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
pre-market | 34 min agoDividend
Analysts recommendations
Institutional Ownership
What type of business is bioAffinity Technologies?
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
What sector is bioAffinity Technologies in?
bioAffinity Technologies is in the Healthcare sector
What industry is bioAffinity Technologies in?
bioAffinity Technologies is in the Diagnostics & Research industry
What country is bioAffinity Technologies from?
bioAffinity Technologies is headquartered in United States
When did bioAffinity Technologies go public?
bioAffinity Technologies initial public offering (IPO) was on 01 September 2022
What is bioAffinity Technologies website?
https://www.bioaffinitytech.com
Is bioAffinity Technologies in the S&P 500?
No, bioAffinity Technologies is not included in the S&P 500 index
Is bioAffinity Technologies in the NASDAQ 100?
No, bioAffinity Technologies is not included in the NASDAQ 100 index
Is bioAffinity Technologies in the Dow Jones?
No, bioAffinity Technologies is not included in the Dow Jones index
When does bioAffinity Technologies report earnings?
Next earnings report date is not announced yet